In breast cancer, NIC reverses the adipocyte-induced epithelial–mesenchymal transition (EMT) in breast cancer cells by inhibiting the interleukin-6/STAT3 signaling axis, thus inhibiting cell migration and invasion ability [51]. This evidence concerns the gene STAT3 and breast carcinoma.